Komori
Other Disclosures4820EM SYSTEMS CO.,LTD.Information and Communications, Services and Others

EM Systems to showcase a demonstration of a prescription data-entry service integrated with the Precal platform at the 59th Annual Meeting of the Japan Pharmaceutical Association

The EMシステムズ Group will exhibit a demonstration of its prescription input service integrated with プレカル for the first time at the 59th Annual Congress of the Japan Pharmaceutical Association, to be held on 11 and 12 October 2026. The commercial version is under development, with release targeted for December 2026.

Worth reading
67In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Neutral
Direction inferred from the company’s description.
Scale
2
Approximately 2-minute demonstration and data returned in an average of 2 minutes
Wording
Conditional
How definitive the wording is.

Announced details

Prescription input service integrated with プレカル
Applicable field (uses covered by this announcement)

Prescription input and pharmacy operations

Launch dateDecember 2026 (target date for release of the commercial version)
What the company reported numerically
Quantitative Effects

Data is returned an average of 2 minutes after transmission of a prescription image. Input accuracy is maintained at a target level of 99% or higher (as of the interim evaluation of the demonstration trial).

Relationship between the counterparty and the company
EM SYSTEMS CO.,LTD.4820
Relationship with the Company

A wholly owned subsidiary in which EMシステムズ holds 100% of the shares. The companies are jointly developing and exhibiting an integrated prescription input service.

Counterparty株式会社プレカル (a wholly owned subsidiary of EMシステムズ)

Room 302, Onden Flat, 1-10-9 Jingumae, Shibuya-ku, Tokyo; President and Representative Director Kobayashi Daigo (小林大悟); development of an automated prescription input system for pharmacies and outsourced prescription input services; capital: ¥100 million

Location (as indicated in this announcement)

Toki Messe Niigata Convention Center (IT Equipment Area), Niigata Prefecture. プレカル's head office is in Shibuya-ku, Tokyo, and EMシステムズ' head office is in Yodogawa-ku, Osaka City, Osaka Prefecture.

Booth JF-8

In this announcement the company addresses none of Contract Value / Offering price / Impact on Business Performance.

Announced details
ItemDetails
Names of Products / Services CoveredPrescription input service integrated with プレカル
Counterparty株式会社プレカル (a wholly owned subsidiary of EMシステムズ)
Counterparty overviewRoom 302, Onden Flat, 1-10-9 Jingumae, Shibuya-ku, Tokyo; President and Representative Director Kobayashi Daigo (小林大悟); development of an automated prescription input system for pharmacies and outsourced prescription input services; capital: ¥100 million
Relationship with the CompanyA wholly owned subsidiary in which EMシステムズ holds 100% of the shares. The companies are jointly developing and exhibiting an integrated prescription input service.
Launch dateDecember 2026 (target date for release of the commercial version)
Applicable areaPrescription input and pharmacy operations
LocationToki Messe Niigata Convention Center (IT Equipment Area), Niigata Prefecture. プレカル's head office is in Shibuya-ku, Tokyo, and EMシステムズ' head office is in Yodogawa-ku, Osaka City, Osaka Prefecture.
Location scaleBooth JF-8
Quantitative EffectsData is returned an average of 2 minutes after transmission of a prescription image. Input accuracy is maintained at a target level of 99% or higher (as of the interim evaluation of the demonstration trial).
Items this document does not state (9)
Contract ValueOffering priceContract DateAward/certification nameAwarding / certifying bodyRegistration number and expiry dateUsage historyImpact on Business PerformanceSource

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

Before releasing the commercial version, the company will give pharmacy professionals an opportunity to see the service in operation and incorporate feedback obtained at the venue into development of the commercial version.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
EM Systems to showcase a demonstration of a prescription data-entry service integrated with the Precal platform at the 59th Annual Meeting of the Japan Pharmaceutical Association | EM SYSTEMS CO.,LTD. (4820) timely disclosure | Komori